Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Ezeprogind

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Ezeprogind, Azp-2006 free base, Tr9yq07eln, 615539-20-3, Asp2006 free base, Unii-tr9yq07eln
    Molecular Formula
    C25H44N6
    Molecular Weight
    428.7  g/mol
    InChI Key
    KLKKWCPJBTXWOV-UHFFFAOYSA-N
    FDA UNII
    TR9YQ07ELN
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-[3-[4-[3-[bis(2-methylpropyl)amino]propyl]piperazin-1-yl]propyl]-1H-benzimidazol-2-amine
    2.1.2 InChI
    InChI=1S/C25H44N6/c1-21(2)19-31(20-22(3)4)14-8-13-30-17-15-29(16-18-30)12-7-11-26-25-27-23-9-5-6-10-24(23)28-25/h5-6,9-10,21-22H,7-8,11-20H2,1-4H3,(H2,26,27,28)
    2.1.3 InChI Key
    KLKKWCPJBTXWOV-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC(C)CN(CCCN1CCN(CC1)CCCNC2=NC3=CC=CC=C3N2)CC(C)C
    2.2 Other Identifiers
    2.2.1 UNII
    TR9YQ07ELN
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Ezeprogind

    2. Azp-2006 Free Base

    3. Tr9yq07eln

    4. 615539-20-3

    5. Asp2006 Free Base

    6. Unii-tr9yq07eln

    7. Chembl419432

    8. 615539-20-3 (free Base)

    9. N-[3-[4-[3-[bis(2-methylpropyl)amino]propyl]piperazin-1-yl]propyl]-1h-benzimidazol-2-amine

    10. N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine

    11. Ezeprogind [inn]

    12. Azp2006 Free Base

    13. Schembl2444189

    14. Klkkwcpjbtxwov-uhfffaoysa-n

    15. Bdbm50134471

    16. Akos040758235

    17. Hy-109172

    18. (1h-benzoimidazol-2-yl)-{3-[4-(3-diisobutylamino-propyl)-piperazin-1-yl]-propyl}-amine

    19. {3-[4-(3-diisobutylamino-propyl)-piperazin-1-yl]-propyl}-(1h-benzimidazol-2-yl)-amine

    20. 1,4-piperazinedipropanamine, N'-1h-benzimidazol-2-yl-n,n-bis(2-methylpropyl)-

    21. 1,4-piperazinedipropanamine, N4-1h-benzimidazol-2-yl-n1,n1-bis(2-methylpropyl)-

    22. N4-1h-benzimidazol-2-yl-n1,n1-bis(2-methylpropyl)-1,4-piperazinedipropanamine

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 428.7 g/mol
    Molecular Formula C25H44N6
    XLogP35.1
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count13
    Exact Mass g/mol
    Monoisotopic Mass g/mol
    Topological Polar Surface Area50.4
    Heavy Atom Count31
    Formal Charge0
    Complexity467
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of progressive supranuclear palsy

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.